NCT03341975 is a NA clinical trial of SexHealth in Sexually Transmitted Diseases, sponsored by Children's Mercy Hospital Kansas City.

Who is sponsoring NCT03341975?

NCT03341975 is sponsored by Children's Mercy Hospital Kansas City.

What drugs are being tested in NCT03341975?

Interventions in NCT03341975: SexHealth.

What condition does NCT03341975 study?

NCT03341975 studies Sexually Transmitted Diseases, Reproductive Behavior.

Is NCT03341975 still recruiting?

NCT03341975 is currently completed. Last updated 25 February 2021.

Are results published for NCT03341975?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2021-02-25 · How we verify

NCT03341975

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Enhanced SexHealth Intervention to Improve Adolescent Outcomes

Completed NA Results posted Last updated 25 February 2021

What this trial tests

NA trial testing SexHealth in Sexually Transmitted Diseases in 91 participants. Completed in 1 May 2020.

Timeline

1 December 2017

Primary endpoint
30 April 2020

1 May 2020

Quick facts

Lead sponsor	Children's Mercy Hospital Kansas City
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	health services research
Enrollment	91
Start date	1 December 2017
Primary completion	30 April 2020
Estimated completion	1 May 2020
Sites	1 location across United States

Drugs / interventions tested

SexHealth

Conditions studied

Sexually Transmitted Diseases — all drugs for Sexually Transmitted Diseases →
Reproductive Behavior — all drugs for Reproductive Behavior →

Sponsor

Children's Mercy Hospital Kansas City

Who can join

Adults 14 to 19, any sex, with Sexually Transmitted Diseases or Reproductive Behavior. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Number of Participants With Uptake of 1 or More Health Services Primary · Index visit

Any 1 or more of the following services: Testing for pregnancy, gonorrhea/chlamydia, and/or HIV, hormonal birth control, condoms, emergency contraception (for immediate or future use), treatment for previously diagnosed (yet untreated) infection with gonorrhea/chlamydia, appointment for clinic referral.

Group	Value	95% CI
Intervention	43
Control	33

Sponsor's own description

This is an adaptive trial with an initial Formative Revision Process followed by a Randomized Controlled Trial (RCT). Up to 500 adolescents will be consented into this study to achieve 6 completed subjects for the formative process and 86 completed subjects for the RCT.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Brief Motivational Intervention to Improve Adolescent Sexual Health Service Uptake: A Pilot Randomized Controlled Trial in the Emergency Department.
Miller MK, Catley D, Adams A, Staggs VS, et al · · 2021 · cited 12× · PMID 34144031 · DOI 10.1016/j.jpeds.2021.06.007

Verify or expand the search:

Other recruiting trials for Sexually Transmitted Diseases

Currently open trials in the same condition.

NCT07072481 — Sustaining Innovative Tools to Expand Youth-Friendly HIV Self-Testing · NA · recruiting
NCT05910580 — Improving Alcohol and Substance Use Care Access, Outcome, Equity During the Reproductive Years · NA · recruiting
NCT06503666 — Zambian Informed Motivated Aware Responsible Adolescent Girls and Adults · NA · recruiting
NCT06579781 — Evaluation of Parent Toolkit 2.0 (Morehouse Family Health Study) · NA · recruiting
NCT05977491 — Point-of-care Tests for Vaginal Discharge in Nepal · NA · active not recruiting

Other Children's Mercy Hospital Kansas City trials

Trials by the same sponsor.

NCT07458568 — ViBandz Feasibility Study · not yet recruiting
NCT07195032 — Safety and Efficacy of Measles, Mumps, Rubella Vaccination in Pediatric Heart Transplantation Patients · Phase 4 · recruiting
NCT06834594 — Bleeding Patterns in Sequential and Continuous Progesterone Supplementation in Adolescents With Turner Syndrome · Phase 4 · recruiting
NCT06738121 — Cosmetic Outcomes of Umbilical Hernia Incisions · NA · completed
NCT06520657 — Addressing Social Determinants of Health in Child Obesity Treatment Using Community Health Workers · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03341975 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Children's Mercy Hospital Kansas City
Last refreshed: 25 February 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03341975.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing